Q BioMed, Inc. operates as a biomedical acceleration and development company. It focuses on acquiring and in-licensing pre-clinical, clinical-stage and approved life sciences therapeutic products. Its products include Strontium-89, MetastronTM, QBM-001, Uttroside-B, and MAN 01. The company was founded by Enrique Navas on November 22, 2013 and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Q BioMed Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Q BioMed Inc market cap is $14,500.00.
What is the 52-week high for Q BioMed Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Q BioMed Inc 52 week high is $0.025 as of October 21, 2025.
What is the 52-week low for Q BioMed Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Q BioMed Inc 52 week low is $0.00 as of October 21, 2025.
What is Q BioMed Inc stock price today?
Q BioMed Inc stock price today is $0.0001.
What was Q BioMed Inc stock price yesterday?
Q BioMed Inc stock price yesterday was $0.0001.
What is the 50-day moving average of Q BioMed Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Q BioMed Inc 50-day moving average is $0.0001.